Investors sold shares of Envision Healthcare Co. (NYSE:EVHC) on strength during trading on Wednesday. $6.31 million flowed into the stock on the tick-up and $36.45 million flowed out of the stock on the tick-down, for a money net flow of $30.14 million out of the stock. Of all stocks tracked, Envision Healthcare had the 19th highest net out-flow for the day. Envision Healthcare traded up $0.15 for the day and closed at $35.07
Several equities analysts have recently commented on the company. Stephens reiterated a “hold” rating and set a $34.00 target price on shares of Envision Healthcare in a research note on Wednesday. Robert W. Baird reduced their target price on Envision Healthcare from $70.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, November 3rd. Zacks Investment Research upgraded Envision Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. Oppenheimer reduced their target price on Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating for the company in a research note on Thursday, November 2nd. Finally, KeyCorp set a $40.00 target price on Envision Healthcare and gave the company a “buy” rating in a research note on Tuesday, November 14th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $40.73.
The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. The stock has a market cap of $4,220.00, a PE ratio of -23.54, a PEG ratio of 1.00 and a beta of 0.57.
Envision Healthcare announced that its Board of Directors has authorized a stock buyback program on Monday, September 18th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 4.5% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.
A number of hedge funds and other institutional investors have recently modified their holdings of EVHC. Janus Henderson Group PLC increased its position in Envision Healthcare by 36,086.8% in the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock worth $247,239,000 after buying an additional 3,934,185 shares during the period. OZ Management LP acquired a new stake in Envision Healthcare in the third quarter worth $131,987,000. Maverick Capital Ltd. increased its position in Envision Healthcare by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after buying an additional 2,028,026 shares during the period. Lord Abbett & CO. LLC increased its position in Envision Healthcare by 259.6% in the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after buying an additional 953,928 shares during the period. Finally, Westfield Capital Management Co. LP acquired a new stake in Envision Healthcare in the second quarter worth $45,892,000.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
What are top analysts saying about Envision Healthcare? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare and related companies.